@article{a8e75b2e2156445bb737957123051bbb,
title = "Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness",
keywords = "Cost-effectiveness analysis, Docetaxel, Prostate cancer",
author = "Woods, {Beth S.} and Eleftherios Sideris and Sydes, {Matthew R.} and Gannon, {Melissa R.} and Parmar, {Mahesh K.B.} and Mymoona Alzouebi and Gerhardt Attard and Birtle, {Alison J.} and Susannah Brock and Richard Cathomas and Chakraborti, {Prabir R.} and Audrey Cook and Cross, {William R.} and Dearnaley, {David P.} and Joanna Gale and Stephanie Gibbs and Graham, {John D.} and Robert Hughes and Jones, {Rob J.} and Robert Laing and Mason, {Malcolm D.} and David Matheson and McLaren, {Duncan B.} and Robin Millman and O'Sullivan, {Joe M.} and Omi Parikh and Parker, {Christopher C.} and Clive Peedell and Andrew Protheroe and Ritchie, {Alastair W.S.} and Angus Robinson and Russell, {J. Martin} and Simms, {Matthew S.} and Srihari, {Narayanan N.} and Rajaguru Srinivasan and Staffurth, {John N.} and Santhanam Sundar and Thalmann, {George N.} and Shaun Tolan and Tran, {Anna T.H.} and David Tsang and John Wagstaff and James, {Nicholas D.} and Sculpher, {Mark J.}",
note = "{\textcopyright} 2018 The Authors",
year = "2018",
month = sep,
day = "14",
doi = "10.1016/j.euo.2018.06.004",
language = "English",
journal = "European Urology Oncology",
issn = "2588-9311",
publisher = "Elsevier",
}
